Glucose Metabolism and Stress Hyperglycemia in Critically Ill Children

Vijay Srinivasan1,2

  • 1Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA, 19104, USA. srinivasan@chop.edu.

Insights

Stress hyperglycemia (SH) in critically ill children is common and linked to poor outcomes. While tight glucose control strategies have shown mixed results, individualized management with advanced monitoring is suggested for better outcomes.

Area of Science:

  • Pediatric Critical Care Medicine
  • Endocrinology
  • Metabolic Disorders

Background:

  • Stress hyperglycemia (SH) is prevalent in critically ill children, potentially impacting outcomes.
  • SH arises from metabolic dysregulation, inflammation, and intensive care unit (ICU) interventions.
  • The role of SH as an adaptive response versus a detrimental factor remains debated.

Purpose of the Study:

  • To review the current understanding of stress hyperglycemia in critically ill children.
  • To evaluate the efficacy and safety of tight glucose control and intensive insulin therapy (TGC-IIT).
  • To identify factors influencing outcomes and suggest future research directions.

Main Methods:

  • Review of existing literature on SH in pediatric critical illness.
  • Analysis of studies investigating TGC-IIT in adult and pediatric populations.
  • Discussion of factors contributing to variability in TGC-IIT outcomes.

Main Results:

  • SH is associated with adverse outcomes in critically ill children.
  • TGC-IIT has yielded conflicting results, with some studies showing benefits and others indicating harm, including increased hypoglycemia.
  • Variability in patient populations, glycemic targets, protocols, and implementation expertise may explain divergent findings.

Conclusions:

  • The management of SH in critically ill children requires careful consideration due to the mixed evidence on TGC-IIT.
  • Individualized approaches to glucose management are necessary.
  • Future research should focus on advanced monitoring, such as continuous glucose sensors and closed-loop systems, for personalized SH management.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
310
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.4K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.9K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.4K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.6K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
23.9K